COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents
NCT ID: NCT04542395
Last Updated: 2022-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2023-06-01
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Increasing Vaccine Uptake in Underresourced Public Housing Areas
NCT04779138
Community-based Behavioral Intervention to Increase Vaccination Using MOST
NCT06614361
Using MOST to Optimize an Intervention to Increase COVID-19 Testing for Frontline Essential Workers
NCT05139927
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
NCT04949243
The Georgia Latino AIDS/HIV Diagnosis and Linkage in Youth (GLADLY) Project
NCT02562092
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Increasing Uptake of COVID-19 Testing and Vaccination
This is a pre-experimental "one group pretest-posttest" design to improve COVID-19 associated health outcomes and willingness and uptake toward testing and vaccination among 310 Hispanic and African American public housing residents in South Los Angeles. The proposed intervention will employ (1) culturally sensitive, (2) theoretically based intervention that will be jointly delivered by our COVID-19 health ambassadors and our researchers. We will use the Information, Motivation, and Behavioral Skills (IMB) model and the Transtheoretical Model to implement the intervention.
Increasing Willingness and Uptake of COVID-19 Testing and Vaccination
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Increasing Willingness and Uptake of COVID-19 Testing and Vaccination
Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 related risk and challenges and increase willingness and uptake in COVID-19 testing and vaccination.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in one of the six collaborating public housing
* 18 years old and older
* Speak either English or Spanish
Exclusion Criteria
* Under the age of 18
* Unable to speak English or Spanish
* Does not Reside in one of the six collaborating public housing
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charles Drew University of Medicine and Science
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohsen Bazargan, PhD
Role: PRINCIPAL_INVESTIGATOR
Charles R. Drew University of Medicine & Science
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Housing Authority of Clty of Los Angeles
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVID19testingvacc
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.